Evidence map›Paper›PMID 40873477›Full record

ArticleBio-protocol2025

Establishing and Maintaining 3D Organoid Cultures From Human Fallopian Tube Epithelium.

David Holthaus, Nina Hedemann, Sophia Theresa Geweniger, Huy Duc Le, Ibrahim Alkatout, Mirjana Kessler, Thomas F Meyer

Abstract read
In one paragraph

Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David HolthausUnit for 3D-Patient Avatars and Personalized Medicine, Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.
Nina HedemannUnit for 3D-Patient Avatars and Personalized Medicine, Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.
Sophia Theresa GewenigerDepartment of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Huy Duc LeDepartment of Gynecology and Obstetrics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.
Ibrahim AlkatoutDepartment of Gynecology and Obstetrics, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.
Mirjana KesslerDepartment of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Thomas F MeyerLaboratory of Infection Oncology, Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The female reproductive tract is comprised of different regions, each with distinctive physiological characteristics. One of them is the fallopian tubes, which are vital for human reproductive health and success. The ability to model their function and physiology is of utmost importance. So far, in vitro models have been based on a few immortalized or cancer cell lines derived from fallopian tube cells that lacked differentiated, specialized cell types and did not allow for the study of cancer initiation due to their implicit biases. Organoids, in contrast, overcome these limitations and provide an advanced, three-dimensional system for the study of healthy fallopian tube physiology and pathology. Fallopian tube organoids are comprised of epithelial progenitors that can be enriched using chemical or hormonal treatment into the different cell types that are found in the in vivo tissue, namely detyrosinated-tubulin-positive ciliated cells or paired-box protein 8 (PAX8)-positive secretory cells. This protocol provides a step-by-step guide for the establishment and maintenance of a long-term culture of organoids from healthy human fallopian tube tissue. The organoid model described here closely mimics the in vivo physiology and anatomy of human fallopian tube epithelium and provides a comprehensive basis for future studies on its underlying molecular characteristics and possible pathology. Key features • Provides a step-by-step guide for the establishment of long-term fallopian tube organoid cultures. • Allows for rapid extension of fallopian tube epithelial progenitor cells with a yield of up to 1 × 10

Indexed as

3D ModelsFallopian tubesFemale reproductive tractOrganoidsReproductive health

Identifiers

PMID40873477
PMCPMC12378425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.